Jeff Glajch
Analyst · Sidoti & Company. Please go ahead
Thank you, Jim and good morning everyone. If you can turn to slide six, sales in the second quarter were $21.1 million, down 7% compared with $22.8 million in the second quarter last year. Sales in the quarter were 73% domestic, 27% international. In last year’s second quarter, the sales split was 67% domestic, 33% international. Domestic sales increased slightly by 1% to $15.4 million, while international sales decreased to 25% to $5.7 million. Gross profit decreased to $5 million, down from $7.1 million last year due to lower margin in backlog, a significant drop in short-cycle sales and lower production volume. Gross margin dropped to 23.7%, down from 31.3% last year. Last year's margin was favorably impacted by productivity improvements as we near the completion of the CVN 79 project, as well as the vendor settlement which occurred within that quarter. EBITDA margin decreased to 11% from 15% in last year's second quarter, driven by lower gross profit margins. SG&A spending was down in the quarter by $1.1 million, or 25%. Approximately two-thirds of this reduction was due to the benefit of insurance proceeds received within the quarter with the remaining one-third due to cost reduction programs completed over the last 12 months. Adjusted net income decreased to $1.4 million from $2 million or $0.14 per share, down from $0.20 per share. The net income number was adjusted for $53,000 after-tax impact for the completion of our restructuring, which has begun in the previous quarter. If you recall, most of the charges occurred in that quarter, but I noted on the end of July I call, that we would have a small amount of charges hitting this quarter also. Looking at slide seven [technical difficulty] the results, sales in the first-half of fiscal 2017 were $43.5 million, down 14% from $50.4 million in the first-half of last year. Year-to-date sales were 73% domestic, 27% international compared with 65% and 35% respectively last year. Domestic sales decreased $1.1 million to $31.7 million this year. International sales were $11.8 million, down from $17.6 million last year. Year-to-date gross profit decreased to $9.1 million from $15.2 million in the prior year. And year-to-date adjusted EBITDA margins were 8%, down from 15% in the first-half of last year. Net income adjusted for the restructuring, which occurred primarily in Q1 was $1.8 million or $0.19 a share, down from $4.3 million or $0.43 a share last year. Looking at slide eight, we continue to have positive operating cash flow, and in the first-half of the year up $3.3 million, of which we paid approximately half of it, or $1.7 million, in dividends to our shareholders. Our cash balance is up $1.2 million from the end of the fiscal year to $66.3 million, or just under $7 per share. Capital spending has been very light this year. Year-to-date at only $200,000 compared with $500,000 in the first-half of last year. We expect full-year capital spending to be between $500,000 and $1 million. Jim, with this -- Jim will complete our presentation by discussing the market outlook and updating our full-year guidance.